Clinical Trials · NCT03611582
Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 611
- Start date
- Aug 2018
- Locations
- 41 sites, United States
- Primary endpoint
- Change in Body Weight (%)